Enter a Search String |
| Special character and space not allowed in the query term. Search string should be at least 2 characters long. |
Molecule Parameter List for CycB | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The statistics table lists the distribution of a molecule acting either as a substrate, product, enzyme or as a molecule within the network. The text color of a molecule is highlighted by color. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statistics | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CycB participated as | Molecule | Sum total of | Enzyme | Substrate of an enzyme | Product of an enzyme | Substrate in Reaction | Product in Reaction |
| No. of occurrences | 1 | 1 | 15 | 3 | 1 | 0 | 1 |
Accession and Pathway Details |
| Accession Name | Accession No. | Accession Type | Pathway Link |
cycle | 85 | Network | Growth, CELLDIV, Rb_grp, IE_GRP, CycB_Grp, Cdc20_Grp, Cdh1_grp, E2F, CycA_Grp, CycE_grp, Early_Response_Genes, Delayed_Response_Genes, CycD_Grp |
| This is a fairly complete mass-action reimplementation of the Novak and Tyson mammalian cell cycle model. It is inexact on two counts. First, it replaces many rather abstracted equations with mass action and Michaelis-Menten forms of enzymes. Second, it does not handle the halving of cellular volume at the division point. Within these limitations, the model does most of what the original paper shows including oscillation of the relevant molecules. | |||
CycB acting as a Molecule in Mammalian_cell_cycle Network
| Name | Accession Name | Pathway Name | Initial Conc. (uM) | Volume (fL) | Buffered |
| CycB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0 | 200 | No |
CycB acting as a Summed Molecule in Mammalian_cell_cycle Network
| Accession Name | Pathway Name | Target | Input |
cycle Accession No. : 85 | CycB_Grp Pathway No. : 1073 | CycB_dup | CycB |
CycB acting as an Enzyme in Mammalian_cell_cycle Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | CycB / k20_lambdaB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 100.002 | 5000 | 4 | explicit E-S complex | Substrate Rb Product Rb_P |
| With Km ~ 0, rate ~ kcat. Here rate = k20 * lambdaB = 10 * 5 7 Apr 2005. Changed to include substrate term. Use Km = 10 >> sub, so kcat = Km * k20 * lambdaB = 10 * 10 * 5 = 500 | ||||||||
| 2 | CycB / k21_phiB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 10 | 200 | 4 | explicit E-S complex | Substrate PP1A Product PP1 |
| phiB = 2. See calculation for k21_phiE | ||||||||
| 3 | CycB / k31 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.00999989 | 0.7 | 4 | explicit E-S complex | Substrate IE Product IEP |
| Represented as k31.[IE].[CycB]/(J31 + [IE]) k31 = 0.7 J31 = 0.01 | ||||||||
| 4 | CycB / k11 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 1 | 3 | 4 | explicit E-S complex | Substrate AminoAcids Product Cdc20notA |
| Represented simply as [CycB]*k11, where k11 is 1.5. As AAs are at 1, we get rate = [AAs].[CycB].kcat / (Km + [AAs]) So if we set Km = [AAs] = 1, then kcat = 3 gives our desired equation. | ||||||||
| 5 | CycB / Cdh1_CycB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.0099998 | 40 | 4 | explicit E-S complex | Substrate Cdh1 Product Cdh1_i |
| Eqn 12. J4 = Km = 0.01 k4 = 40 GammaB = 1 kcat = k4 * GammaB = 40 | ||||||||
| 6 | CycB / B_phosph_E2FA | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 10 | 4 | explicit E-S complex | Substrate E2FA Product E2FAP |
| See A_phosph_E2F. Same rate of k23 = 1 applies. | ||||||||
| 7 | CycB / E2FA.Rb | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 10 | 4 | explicit E-S complex | Substrate E2FA.Rb Product E2FAP.Rb |
| See A_phosph_E2F. Same rate of k23 = 1 applies. | ||||||||
| 8 | CycB / Ak6_etaB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 1000 | 4 | explicit E-S complex | Substrate CycA_Kip1 Product CycA degraded |
| See Ak6_etaE | ||||||||
| 9 | CycB / k8_CycB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.0999992 | 0.1 | 4 | explicit E-S complex | Substrate CycE Product degraded |
| 10 | CycB / k6_E_etaB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 1000 | 4 | explicit E-S complex | Substrate CycE_Kip1 Product CycE degraded |
| See notes for k6_E_etaE. Here etaB = 1 so kcat = 1000, Km as before is 10 | ||||||||
| 11 | CycB / k6_D_etaB | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 1000 | 4 | explicit E-S complex | Substrate CycD_Kip1 Product CycD degraded |
| 6 Apr 2005. Earlier used explicit E.S complex form with k1 = 1000, k2 = 10, k3 = 1. This gave low Km and lots of E.S. complex. So shift to MM form: k6 = 100, etaB = 1. Let Km = 10 >> substrate. Then kcat = Km * k6 * etaB = 1000 | ||||||||
| 12 | CycB / k8_CycB_Kip1 | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 0.0999992 | 0.1 | 4 | explicit E-S complex | Substrate CycE_Kip1 Product Kip1 degraded |
| k8 = 0.2, psiB = 0.05, so kcat = 0.1. J8 = 0.1 | ||||||||
| 13 | CycB / k6_kip1_B | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 9.99992 | 1000 | 4 | explicit E-S complex | Substrate Kip1 Product degraded_kip |
| 6 Apr 2005. Using MM form: k6 = 100 Let Km = 10 >> substrate. Then kcat = Km * k6 * eta_B = 1000 | ||||||||
| 14 | CycB / k20_lambdaB[1] | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 100.002 | 5000 | 4 | explicit E-S complex | Substrate E2FAP.Rb Product E2FAP Rb_P |
| With Km ~ 0, rate ~ kcat. Here rate = k20 * lambdaB = 10 * 5 7 Apr 2005. Changed to include substrate term. Use Km = 10 >> sub, so kcat = Km * k20 * lambdaB = 10 * 10 * 5 = 500 | ||||||||
| 15 | CycB / k20_lambdaB[2] | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 100.002 | 5000 | 4 | explicit E-S complex | Substrate E2FA.Rb Product E2FA Rb_P |
| With Km ~ 0, rate ~ kcat. Here rate = k20 * lambdaB = 10 * 5 7 Apr 2005. Changed to include substrate term. Use Km = 10 >> sub, so kcat = Km * k20 * lambdaB = 10 * 10 * 5 = 500 | ||||||||
CycB acting as a Substrate for an Enzyme in Mammalian_cell_cycle Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents | |
| 1 | Cdc20 / k2_prime_prime | cycle Accession No. : 85 | CELLDIV Pathway No. : 1070 | 99.9992 | 100 | 4 | explicit E-S complex | Substrate CycB Product degraded |
| k2_prime_prime = 1. rate = k2_prime_prime * Cdc20 * CycB Using MM: rate = kcat * Cdc20 * CycB / (CycB + Km) Let Km >> CycB, ie, around 100. Then kcat = k2_prime_prime * Km = 100. | ||||||||
| 2 | Cdh1_i / Cdh1_i_k2_prime | cycle Accession No. : 85 | Cdh1_grp Pathway No. : 1075 | 100.002 | 5 | 4 | explicit E-S complex | Substrate CycB Product degraded |
| k2_prime = 0.05. so actually this reaction is pretty negligible. rate = k2_prime * Cdh1_i * CycB From MM kinetics, rate = kcat * Cdh1_i * CycB / (CycB + Km). Let Km >>CycB, so Km = 10. Then kcat = k2_prime * Km = 0.5 | ||||||||
| 3 | Cdh1 / Cdh1_k2 | cycle Accession No. : 85 | Cdh1_grp Pathway No. : 1075 | 100 | 2000 | 4 | explicit E-S complex | Substrate CycB Product degraded |
| k2 = 20 Let Km = 100, so it is >> substrate. Then kcat = Km * k2 = 2000 | ||||||||
CycB acting as a Product of an Enzyme in Mammalian_cell_cycle Network
| Enzyme Molecule / Enzyme Activity | Accession Name | Pathway Name | Km (uM) | kcat (s^-1) | Ratio | Enzyme Type | Reagents |
| CycB_synth / k1 | cycle Accession No. : 85 | CycB_Grp Pathway No. : 1073 | 0.01 | 0.6 | 4 | explicit E-S complex | Substrate CycB_dimer Product CycB |
| k1 = 0.6. J1 = 0.1 rate = k1([CycB]/J1)^2 / (1 + ([cycB]/J1)^2 ) 2nd order term comes from dimerization, assume rate = k1 * dimer. Doing our usual assumption of AA = Km = 1, we get kcat = 2 * k1 = 1.2 7 April. Revisit this. Multiply expression above and below by J1^2. Then we have standard MM form, with k1 = kcat, and J1^2 = Km. 19 Apr 2005. Altered layout so that dimer form is in substrate, which it should have been all along. | |||||||
CycB acting as a Product in a reaction in Mammalian_cell_cycle Network
| Kd is calculated only for second order reactions, like nA+nB <->nC or nA<->nC+nD, where n is number and A,B,C,D are molecules, where as for first order reactions Keq is calculated. Kd for higher order reaction are not consider. |
| Name | Accession Name | Pathway Name | Kf | Kb | Kd | tau | Reagents |
| k1_prime | cycle Accession No. : 85 | CycB_Grp Pathway No. : 1073 | 0.1 (s^-1) | 0 (s^-1) | - | - | Substrate AminoAcids Product CycB |
| k1_prime = 0.1 | |||||||
color.